Mega Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	508.93	518.29	399.83	239.1	208.45	52.65
Short-Term Investments	-	7.98	8.7	223.53	5.8	12.75
Cash & Short-Term Investments	508.93	526.27	408.53	462.63	214.25	65.4
Cash Growth	18.18%	28.82%	-11.69%	115.93%	227.61%	-
Accounts Receivable	150.39	115.88	184.82	203.63	130.23	108.13
Other Receivables	-	-	5.53	0.04	0.71	2.17
Receivables	150.39	115.88	190.36	203.67	130.94	110.3
Inventory	1.21	4.41	3.51	3.28	2.97	2.44
Other Current Assets	50.41	21.22	16.69	15.78	9.95	6.25
Total Current Assets	710.94	667.78	619.08	685.36	358.11	184.38
Property, Plant & Equipment	87.55	94.05	46.91	51.13	62.24	75.41
Long-Term Investments	29.6	29.6	30.03	30.2	30.14	-
Other Intangible Assets	0.85	0.92	0.83	0.81	0.65	0.75
Long-Term Deferred Tax Assets	3.13	4.2	5.97	2.81	2.06	3.11
Other Long-Term Assets	-	-	2.88	1.88	0.37	0.1
Total Assets	832.07	796.54	705.7	772.18	453.57	263.75
Accounts Payable	48.25	39.54	34.76	29.2	26.88	12
Accrued Expenses	-	6.19	7.95	15.68	7.17	8.53
Current Portion of Long-Term Debt	1.95	1.91	-	-	2.65	10.41
Current Portion of Leases	2.1	10.62	6.48	6.22	8.44	6.26
Current Income Taxes Payable	3.24	0.6	0.12	6.53	0.2	-
Current Unearned Revenue	0.6	52.87	10.46	10.7	11.5	13.81
Other Current Liabilities	74.86	2.61	21.48	1.47	205.52	2.06
Total Current Liabilities	131.01	114.33	81.25	69.79	262.37	53.07
Long-Term Debt	19.74	20.72	-	-	-	2.65
Long-Term Leases	17.63	15.31	4.51	5.35	11.66	17.53
Long-Term Unearned Revenue	1.05	1.35	1.95	2.55	3.15	3.75
Other Long-Term Liabilities	-	-	-	-	-	189.44
Total Liabilities	169.43	151.72	87.7	77.69	277.18	266.45
Common Stock	0.15	0.15	0.16	0.13	-	-
Additional Paid-In Capital	370.13	385.57	394.49	228.69	-	-
Retained Earnings	168.63	131.66	101.63	119.24	40.23	-38.87
Treasury Stock	-6.5	-1.57	-	-	-	-
Comprehensive Income & Other	130.22	129.01	121.72	346.44	136.17	36.17
Shareholders' Equity	662.64	644.83	618	694.5	176.4	-2.7
Total Liabilities & Equity	832.07	796.54	705.7	772.18	453.57	263.75
Total Debt	41.42	48.56	10.99	11.57	22.76	36.85
Net Cash (Debt)	467.51	477.71	397.55	451.06	191.49	28.54
Net Cash Growth	11.31%	20.16%	-11.86%	135.56%	570.85%	-
Net Cash Per Share	2.27	2.26	1.93	3.54	-	-
Filing Date Shares Outstanding	235.61	237.77	239.23	200	-	-
Total Common Shares Outstanding	235.61	237.77	239.23	200	-	-
Working Capital	579.93	553.45	537.83	615.57	95.74	131.31
Book Value Per Share	2.81	2.71	2.58	3.47	-	-
Tangible Book Value	661.79	643.91	617.16	693.69	175.74	-3.45
Tangible Book Value Per Share	2.81	2.71	2.58	3.47	-	-
Machinery	-	72.71	69.91	68.6	66.19	65.63
Construction In Progress	-	34.74	-	-	-	-
Leasehold Improvements	-	12.51	11.33	8.63	8.38	8.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.